[go: up one dir, main page]

RU2006119994A - ANTUBERCULOSIS PHARMACEUTICAL COMPOSITION - Google Patents

ANTUBERCULOSIS PHARMACEUTICAL COMPOSITION Download PDF

Info

Publication number
RU2006119994A
RU2006119994A RU2006119994/15A RU2006119994A RU2006119994A RU 2006119994 A RU2006119994 A RU 2006119994A RU 2006119994/15 A RU2006119994/15 A RU 2006119994/15A RU 2006119994 A RU2006119994 A RU 2006119994A RU 2006119994 A RU2006119994 A RU 2006119994A
Authority
RU
Russia
Prior art keywords
pharmaceutical composition
antuberculosis
isoniazid
acid hydrazide
isonicotinic acid
Prior art date
Application number
RU2006119994/15A
Other languages
Russian (ru)
Inventor
Екатерина Сергеевна Кондакова (RU)
Екатерина Сергеевна Кондакова
Виталий Ильич Литвинов (RU)
Виталий Ильич Литвинов
Петр Петрович Сельцовский (RU)
Петр Петрович Сельцовский
Сергей Эмильевич Кондаков (RU)
Сергей Эмильевич Кондаков
Original Assignee
Общество с ограниченной ответственностью "Комелис" (RU)
Общество с ограниченной ответственностью "Комелис"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "Комелис" (RU), Общество с ограниченной ответственностью "Комелис" filed Critical Общество с ограниченной ответственностью "Комелис" (RU)
Priority to RU2006119994/15A priority Critical patent/RU2006119994A/en
Publication of RU2006119994A publication Critical patent/RU2006119994A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (1)

Противотуберкулезная фармацевтическая композиция, включающая в качестве действующего вещества изониазид (гидразид изоникотиновой кислоты) и целевые добавки, отличающаяся тем, что она содержит терапевтически эффективное количество изониазида (гидразид изоникотиновой кислоты), а в качестве целевых добавок она содержит цветочную пыльцу в соотношении от 1:1 до 1:100 от массы действующего вещества и фармацевтически приемлемый носитель остальное.An anti-tuberculosis pharmaceutical composition comprising isoniazid (isonicotinic acid hydrazide) and target additives as an active ingredient, characterized in that it contains a therapeutically effective amount of isoniazid (isonicotinic acid hydrazide), and as target additives it contains pollen in a ratio of 1: 1 up to 1: 100 by weight of the active substance; and the rest is a pharmaceutically acceptable carrier.
RU2006119994/15A 2006-06-08 2006-06-08 ANTUBERCULOSIS PHARMACEUTICAL COMPOSITION RU2006119994A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2006119994/15A RU2006119994A (en) 2006-06-08 2006-06-08 ANTUBERCULOSIS PHARMACEUTICAL COMPOSITION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2006119994/15A RU2006119994A (en) 2006-06-08 2006-06-08 ANTUBERCULOSIS PHARMACEUTICAL COMPOSITION

Publications (1)

Publication Number Publication Date
RU2006119994A true RU2006119994A (en) 2007-12-27

Family

ID=39018408

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006119994/15A RU2006119994A (en) 2006-06-08 2006-06-08 ANTUBERCULOSIS PHARMACEUTICAL COMPOSITION

Country Status (1)

Country Link
RU (1) RU2006119994A (en)

Similar Documents

Publication Publication Date Title
RU2401658C2 (en) Heterocyclic aspartylprotease inhibitors
NO20064670L (en) Galenic formulations of organic compounds
EA200700049A1 (en) PREPARATIVE FORMS OF ORAL MEDICINAL FORMS OF MEMANTINE WITH MODIFIED SURVIVAL
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
WO2005034908A3 (en) A solid dosage form comprising a fibrate and a statin
JP2010530431A5 (en)
BRPI0513841A (en) compound, pharmaceutical composition, and compound use
MY143795A (en) Tetrahydropyridoindole derivatives
NO20076219L (en) Pharmaceutical formulation with apomorphine for buccal administration
WO2011118976A3 (en) Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
ATE487720T1 (en) 5,6,7,8-TETRAHYDROPTERIDINE DERIVATIVES AS HSP90 INHIBITORS
EA200800360A1 (en) FORMS WITH HIGH CONTENT OF DRUGS AND DOSED FORMS
UA101407C2 (en) STABLE COMBINED PHARMACEUTICAL COMPOSITION OF AMLODIPINE AND BISOPROLOL FUMARATE
CL2009001267A1 (en) Compounds derived from nitrogenous tricycles, with antibacterial activity; preparation procedure; pharmaceutical composition comprising them; for the treatment of tuberculosis.
MX2010004556A (en) Pharmaceutical formulation of clavulanic acid.
DK1677777T3 (en) Pellets containing venlafaxine hydrochloride
EA200702593A1 (en) HIGHLY CONCENTRATED COMPOSITIONS APPLICABLE FOR THE FIGHT AGAINST ECO AND END-PARASITES
BR0306732A (en) Combination treatments for allergic disease comprising administering an anti-ige antibody and antiallergic compound
WO2020246750A3 (en) Pharmaceutical composition containing stabilized nucleic acid adjuvant
MA32722B1 (en) GALENIC FORMULATION COMPRISING ALISKIRENE AND ASSOCIATED PREPARATION METHOD BY FUSION-EXTRUSION GRANULATION
WO2019016673A3 (en) A stable oral pharmaceutical composition of imatinib
EA200801614A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING MONTELUKAST
RU2006119994A (en) ANTUBERCULOSIS PHARMACEUTICAL COMPOSITION
EA200601368A1 (en) Macrolides with anti-inflammatory activity.
RU2009145804A (en) AXOMADOL FOR TREATING PAIN FROM ARTHROSIS

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20090812